§ 862.3100. Amphetamine test system.
188 words·~1 min read·
/us/cfr/t21/s§ 862.3100·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.
(b)Classification. Class II (special controls). An amphetamine test system is not exempt if it is intended for any use other than employment or insurance testing or is intended for Federal drug testing programs. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing, and does not include devices intended for Federal drug testing programs (e.g., programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military). [52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019]
Connections2 cite this
Cited by 2 sections
Citation graph
cites case law
§ 862.3100
Amphetamine test system.
Fed. Reg.×2
Cites 0Cited by 2 across 1 source